KARDD to Hold First Symposium on Dec. 17, Discussing Development of Aging Therapies

[Financial News] A forum will bring together researchers from Korea and abroad and the pharmaceutical and biotech industries to share the latest research findings, from identifying the mechanisms of aging to developing and commercializing therapeutics.
The Korean Association for Research on Aging and Drug Development (KARDD) announced on the 27th that it will hold the 1st KARDD Symposium 2026 on December 17 in the auditorium on the fourth floor of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association in Seocho-gu, Seoul.
Held under the theme “Aging Science to Therapeutics,” the event will cover basic research, clinical applications and the industry’s strategies for developing new drugs. Following opening remarks by KARDD Chairman Kim Yong-sun, Lee Seung-gyu, vice chairman of the Korea Biotechnology Industry Organization (KBIO), and Park Young-min, head of the Korea Drug Development Fund (KDDF), are scheduled to deliver congratulatory remarks.
The first session will discuss topics including noncoding RNA homeostasis, growth factor signaling in cancer and cellular aging, and strategies for developing therapies that target immune aging. The second session will focus on muscle aging and present partial reprogramming of muscle stem cells, a digital twin prediction model for skeletal muscle aging, and the potential therapeutic applications of the exercise-derived factor AMPEX.
The third session will cover obesity and metabolic disease risks, as well as the clinical application of test-based aging clocks. Biotech companies including Pyo Biotech, Senerix and ReversAge Labs will also participate and are scheduled to present their pipelines for developing aging-related therapeutics.
The event is intended for clinicians, researchers at universities and research institutes, professionals in the pharmaceutical and biotech industries, and venture capital (VC) representatives, among others. Registration is open through November 8 on the event information page of BioIN, a bio-information portal, and will be handled on a first-come, first-served basis.

[email protected] Jeong Sang-hee Reporter